Correction to: The majority of β-catenin mutations in colorectal cancer is homozygous

BMC Cancer. 2020 Nov 26;20(1):1151. doi: 10.1186/s12885-020-07645-z.

¹ Institute of Pathology, Charité - Universitätsmedizin Berlin, Virchoweg 15 / Charitéplatz 1, 10117, Berlin, Germany. alexander.arnold@charite.de.
² Institute of Pathology, Charité - Universitätsmedizin Berlin, Virchoweg 15 / Charitéplatz 1, 10117, Berlin, Germany.
³ Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg; Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ); Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg, Heidelberg, Germany.
⁴ Department of General Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
⁵ Present address: Institute of Pathology, Universitätsklinikum Leipzig, Leipzig, Germany.

Abstract

An amendment to this paper has been published and can be accessed via the original article.